[ad_1]
Supply of a new vaccine against coronavirus infection (Corona 19) in Europe is showing signs of confusion, including governments warning a lawsuit against vaccine manufacturers, but the government said: “There is no problem with the national plan. supply of vaccines “.
Astra 1Q EU supply reduced by 60%
Pfizer Shipping Reduction … North American Road Emergency
New York State “97% of vaccines are already out of stock”
Government of Korea “There were no supply and demand problems in the first quarter”
Reuters reported on the 23rd that “the initial supply of vaccines from the University of Oxford and AstraZeneca to the European Union in the first quarter of this year is expected to be 31 million doses.” The Astra vaccine is expected to be supplied to 27 EU member states from the middle of next month with approval from the European Medicines Agency (EMA) later this month. The Wall Street Journal (WSJ) reported that AstraZeneca was working late to improve productivity.
The initial supply of Pfizer-Bioentech vaccines, which the EU has contracted for 600 million doses, is also expected to decline. Previously, Pfizer said it would reduce vaccine shipments in the coming weeks with the expansion of its Belgian production facility. As a result, vaccination in Europe and North America is discontinuing. The BBC reported on the 22nd that vaccines were temporarily suspended in Germany’s North Rhine-Westphalia and several regions of Italy, and that in Madrid, Spain, vaccines were also suspended. EU member states such as Italy, Germany and Spain recently announced that vaccine supply has decreased by 20-50% over the plan. Canadian health officials said that Pfizer has delayed delivery of supplies to next week and that supplies will be significantly reduced over the next three weeks.
Some European countries are even pushing for legal action against vaccine suppliers. Italian Prime Minister Giuseppe Conte said on his Facebook page on the 23rd that “AstraZeneca’s reduction in the supply of vaccines is a serious breach of contract and will consider all legal actions.” Poland also warned of legal action against AstraZeneca and Pfizer. Hungary has approved and signed a supply contract for the Russian Sputnik V vaccine, which has not been approved by the EU.
Vaccine shortages have also been noted in the United States. New York Governor Andrew Cuomo said on the 22nd that “97% of the amount of vaccine supplied has been used and will soon run out.” Louisiana and New Jersey also complained about a lack of vaccines.
In this situation, the Central Defense Response Center of the Korea Centers for Disease Control and Prevention said on the 24th that “Korea will receive the AstraZeneca vaccine produced by SK Bioscience from the first quarter, and there has been no change in the plan so far. ” The government believes there will be no supply disruptions as Korea receives domestically produced vaccines. In Korea, SK Bioscience is commissioned to produce the AstraZeneca vaccine and the NovaVax vaccine.
In early February, Korea plans to inoculate 50,000 Pfizer vaccines to the frontline of medical staff caring for corona19 patients before the Lunar New Year holidays through the COVAX (multinational method of joint purchasing of vaccines) facility. In mid-February, 750,000 domestically produced AstraZeneca vaccines will be launched first. The AstraZeneca vaccine will be given sequentially to 10 million people.
20 million people for the Modena vaccine and 6 million people for the Janssen vaccine will arrive in the second quarter, and 10 million people for Pfizer will arrive in the third quarter. The NovaVax vaccine will also supply 20 million domestically produced vaccines through a technology introduction contract with SK Bioscience. A total of 10 million vaccines have previously been purchased through COVAX, but it is unclear when and what type of vaccine will be available in addition to the first batch of 50,000 Pfizer vaccines.
Reporter Esther and Seok Kyung-min [email protected]
[ad_2]
